Preferences about Future Alzheimer’s Disease Treatments Elicited through an Online Survey Using the Threshold Technique
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Preferences about Future Alzheimer’s Disease Treatments Elicited through an Online Survey Using the Threshold Technique ; day:30 ; month:6 ; year:2023 ; pages:1-9
The journal of prevention of Alzheimer's disease ; (30.6.2023), 1-9
- Urheber
-
Munoz, Sonia Roldan
de Vries, S. T.
Lankester, G.
Pignatti, F.
van Munster, B. C.
Radford, I.
Guizzaro, L.
Mol, P. G. M.
Hillege, H.
Postmus, D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2023.84
- URN
-
urn:nbn:de:101:1-2023092710422452458487
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Munoz, Sonia Roldan
- de Vries, S. T.
- Lankester, G.
- Pignatti, F.
- van Munster, B. C.
- Radford, I.
- Guizzaro, L.
- Mol, P. G. M.
- Hillege, H.
- Postmus, D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Central syntropic effects elicited by trigeminal proprioceptive equilibrium in Alzheimer’s disease: a case report
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Therapeutic preference for Alzheimer’s disease treatments: a discrete choice experiment with caregivers and neurologists
Methodological quality of systematic reviews on treatments for Alzheimer’s disease: a cross-sectional study
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Central syntropic effects elicited by trigeminal proprioceptive equilibrium in Alzheimer’s disease: a case report
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Therapeutic preference for Alzheimer’s disease treatments: a discrete choice experiment with caregivers and neurologists
Methodological quality of systematic reviews on treatments for Alzheimer’s disease: a cross-sectional study
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Central syntropic effects elicited by trigeminal proprioceptive equilibrium in Alzheimer’s disease: a case report
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Therapeutic preference for Alzheimer’s disease treatments: a discrete choice experiment with caregivers and neurologists